Source:http://linkedlifedata.com/resource/pubmed/id/12008172
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2002-5-14
|
pubmed:abstractText |
Enhanced external counterpulsation (EECP) has recently emerged as a treatment option for angina in selected patients suitable for revascularization with percutaneous coronary intervention (PCI). We compared baseline characteristics and 1-year outcome in 2 cohorts of PCI candidates presenting with stable symptoms: 323 patients treated with EECP in the International EECP Patient Registry (IEPR), and 448 NHLBI Dynamic Registry patients treated with elective PCI. Compared with patients receiving PCI, IEPR patients had a higher prevalence of many risk factors including prior PCI (53.0% vs 33.3%, p <0.001), prior coronary artery bypass grafting (42.1% vs 18.6%, p <0.001), prior myocardial infarction (56.4% vs 27.8%, p <0.001), history of congestive heart failure (16.8% vs 9.2%, p <0.01), and history of diabetes (37.9% vs 23.5%, p <0.001). Left ventricular ejection fraction was lower among IEPR patients (mean 50.3% vs 59.2%, p <0.001). At 1 year, survival was comparable in the 2 cohorts (98.7% IEPR vs 96.8% PCI, p = NS), as were rates of coronary artery bypass grafting during follow-up (4.5% IEPR vs 5.7% PCI, p = NS). At 1 year, 43.7% of IEPR patients reported no anginal symptoms compared with 73.4% of Dynamic Registry patients (p <0.001). Rates of severe symptoms (Canadian Cardiovascular Society class III, IV, or unstable) at 1 year were 15.5% among IEPR patients and 9.5% in the Dynamic Registry (p = 0.02). PCI candidates suitable for and treated with EECP had 1-year major event rates comparable to patients receiving elective PCI. Although PCI was associated with substantially lower rates of 1-year symptoms, EECP may be a safe treatment option for selected patients with obstructive coronary disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0002-9149
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1182-6
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12008172-Age Factors,
pubmed-meshheading:12008172-Aged,
pubmed-meshheading:12008172-Angina Pectoris,
pubmed-meshheading:12008172-Cohort Studies,
pubmed-meshheading:12008172-Coronary Artery Bypass,
pubmed-meshheading:12008172-Counterpulsation,
pubmed-meshheading:12008172-Female,
pubmed-meshheading:12008172-Follow-Up Studies,
pubmed-meshheading:12008172-Humans,
pubmed-meshheading:12008172-Male,
pubmed-meshheading:12008172-Middle Aged,
pubmed-meshheading:12008172-Population Dynamics,
pubmed-meshheading:12008172-Recurrence,
pubmed-meshheading:12008172-Registries,
pubmed-meshheading:12008172-Severity of Illness Index,
pubmed-meshheading:12008172-Stroke Volume,
pubmed-meshheading:12008172-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Comparison of patients undergoing enhanced external counterpulsation and percutaneous coronary intervention for stable angina pectoris.
|
pubmed:affiliation |
Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Multicenter Study
|